TP53 and neoplasm: After treatment with LF3, a specific blocker of β-catenin binding to TCF4, the Wnt/β-catenin protein level did not change significantly, but the expression level of TCF4 was reduced in TP53 knockdown tumor cells, which may result from reduced β-catenin/TCF4 dimer.